EyeSense AG
EyeSense is a pioneering company in medical technology, focusing on innovative continuous glucose monitoring systems. With a mission to improve quality of life for those with chronic conditions, they develop precise, sustainable, and user-friendly health monitoring solutions. Their FiberSense platform extends beyond blood glucose measurement to include a broad spectrum of biometric data, aiming to revolutionize health monitoring and personalized medicine.
Industries
Nr. of Employees
small (1-50)
EyeSense AG
Products
Continuous optical fiber-based glucose monitoring system (in approval phase)
A wearable system using a fiber-optic sensor with a hydrogel-embedded biosensor chemistry to continuously measure glucose concentration in tissue fluid beneath the skin and wirelessly transmit real-time data to a smartphone app. The system is described as supporting up to four weeks wear and reusable electronic components; it is reported to be in regulatory approval processes and not yet a marketed device.
Continuous optical fiber-based glucose monitoring system (in approval phase)
A wearable system using a fiber-optic sensor with a hydrogel-embedded biosensor chemistry to continuously measure glucose concentration in tissue fluid beneath the skin and wirelessly transmit real-time data to a smartphone app. The system is described as supporting up to four weeks wear and reusable electronic components; it is reported to be in regulatory approval processes and not yet a marketed device.
Expertise Areas
- Continuous glucose monitoring
- Optical biosensing
- Hydrogel-based biosensor chemistry
- Clinical study execution and performance validation
Key Technologies
- Fiber-optic sensing
- Hydrogel-embedded biosensors
- Photometric biomarker detection
- Low-volume sensor dispensing (nanoliter-scale)